CStone Pharmaceuticals
Suzhou
About CStone Pharmaceuticals
CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative tumor immunotherapy and precision treatment drugs to meet the intensive medical needs of cancer patients in China and around the world.CStone Pharmaceuticals has assembled a world-class management team with extensive experience in new drug development, clinical research, and commercialization. The company has built a rich product pipeline composed of 15 tumor candidate drugs with the combination of tumor immunotherapy as the core.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $472.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: hkg:2616
- Website: cstonepharma.com
- Phone: + 86-(0)512-8718-6550
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cstone-pharmaceuticals-138836 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.